News //

HRC provides major funding boost for MWC investigators

25 June 2018

The Health Research Council of New Zealand (HRC) has announced the results of its 2018 funding round, which includes funding awarded for a new programme and a number of projects led by MWC investigators.

The HRC supports research that has the potential to improve health outcomes, delivery of healthcare, and to produce economic gain for New Zealand.

The Maurice Wilkins Centre extends its congratulations to all of our investigators who received funding for their research, as well as to the Malaghan Institute of Medical Research that received an Independent Research Organisation (IRO) funding grant of more than $10 million over the next three years.

Funding awarded to investigators in the Maurice Wilkins Centre network in the 2018 annual funding round include:



Professor Peter Shepherd, University of Auckland

Understanding genetic risk factors for metabolic disease in Maori and Pacific



Professor David Ackerley, Victoria University of Wellington

Repurposing the anthelmentic niclosamide to combat Gram negative superbugs

Professor Michael Baker, University of Otago, Wellington

Developing an optimal strategy for the rheumatic fever endgame

Professor Margaret Brimble, University of Auckland

Naturally occurring peptaibols: “Magic bullets” for targeting breast cancer

Professor Michael Eccles, University of Otago, Dunedin

Epigenomic profiling to predict patient response to melanoma immunotherapy

Dr Bronwyn Kivell, Victoria University of Wellington

Development of novel remyelination treatments for multiple sclerosis

Dr Peter Mace, University of Otago, Dunedin

Understanding regulation of the polycomb-repressive deubiquitinase in malignancy

Professor Sally McCormick, University of Otago, Dunedin

Targeting new receptors for lipoprotein(a)

Professor Mark McKeage, University of Auckland

Reducing oxaliplatin toxicity: A randomised dose-finding proof-of-concept trial

Associate Professor Adam Patterson, University of Auckland

Banishing tumour hypoxia to render cancer immunotherapy curative

Professor Franca Ronchese, Malaghan Institute of Medical Research

Molecular characterisation of dendritic cells during immune responses

Professor Peter Shepherd, University of Auckland

A new combination therapy for cancer


Emerging Researcher First Grant:

Dr Brie Sorrenson, University of Auckland

Understanding genetic factors that influence beta-cell function


For further details about the funding for these projects, please see the HRC website.